Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04271670
Other study ID # SWI_03
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 15, 2016
Est. completion date September 18, 2017

Study information

Verified date February 2020
Source ARCIM Institute Academic Research in Complementary and Integrative Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A randomized, controlled, three-arm trial to investigate the effects of warm water footbaths with and without the addition of ginger or mustard powder on psychosocial parameters in patients with an oncological disease and in healthy controls.


Description:

A randomized, controlled trial with cross-over design in which the subjects (23 patients with an oncological disease, 13 healthy controls) receive warm water footbaths with added ginger (experimental) or mustard powder (experimental) or without additives (active comparator). The wash-out period between two consecutive footbath interventions is at least one day. Outcome measures are assessed right before (t1), right after (t2) and 10 minutes following the footbath (t3). The main focus is on the change in subjective perception of warmth distribution between t1 and t3. Moreover, the objective skin temperature distribution and psychosocial scores are assessed. The primary outcome measure is analyzed with a linear mixed effects model (after checking for carry-over effects). Secondary outcome measures are described descriptively.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date September 18, 2017
Est. primary completion date September 18, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Written informed consent

- Age between 18 and 65 years

- Oncological disorder with at least one chemotherapy or radiation in the treatment history

- Current inpatient treatment in the oncology ward of the Filderklinik (Filderstadt, Germany) with a minimum stay of 4 days

Exclusion Criteria:

- Infectious disease (with more than 38 °C core body temperature)

- Skin lesion on the lower legs or feet

- Hypersensitivity to mustard or ginger products

- Cardiac arrhythmia

- Pregnancy

- Insufficient knowledge of the German language

- Bedriddenness

- Poor general condition (according to the assessment of the attending physicians)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Ginger powder footbaths
20-minute footbath with 12 liters of 40°C warm water and an additive of 80g dried ginger powder (reaching up to mid-calf level)
Mustard powder footbaths
20-minute footbath with 12 liters of 40° C warm water and an additive of 80g dried mustard powder (reaching up to mid-calf level)
Warm water only footbaths
20-minute footbath with 12 liters of 40° C warm water without any additive (reaching up to mid-calf level)

Locations

Country Name City State
Germany Arcim Institute Filderstadt Baden-Württemberg

Sponsors (1)

Lead Sponsor Collaborator
ARCIM Institute Academic Research in Complementary and Integrative Medicine

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in subjective feeling of warmth at the feet as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t3 Self-reported feeling of warmth at the feet, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot Immediately before the footbath (t1) and 10 minutes following the footbath (t3)
Secondary Change in subjective feeling of warmth at the feet as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t2 Self-reported feeling of warmth at the feet, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot Immediately before the footbath (t1) and immediately after the footbath (t2)
Secondary Change in subjective feeling of warmth in the face as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t3 Self-reported feeling of warmth in the face, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot Immediately before the footbath (t1) and 10 minutes following the footbath (t3)
Secondary Change in subjective feeling of warmth in the face as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t2 Self-reported feeling of warmth in the face, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot Immediately before the footbath (t1) and immediately after the footbath (t2)
Secondary Change in subjective feeling of warmth at the hands as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t3 Self-reported feeling of warmth at the hands, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot Immediately before the footbath (t1) and 10 minutes following the footbath (t3)
Secondary Change in subjective feeling of warmth at the hands as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t2 Self-reported feeling of warmth at the hands, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot Immediately before the footbath (t1) and immediately after the footbath (t2)
Secondary Change in subjective feeling of overall warmth as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t3 Self-reported feeling of overall warmth, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot Immediately before the footbath (t1) and 10 minutes following the footbath (t3)
Secondary Change in subjective feeling of overall warmth as assessed by the "Herdecke Warmth Perception Questionnaire" from t1 to t2 Self-reported feeling of overall warmth, measured with the "Herdecke Warmth Perception Questionnaire", score between 0=cold and 4=hot Immediately before the footbath (t1) and immediately after the footbath (t2)
Secondary Warmth perception and skin stimulus at the feet during the footbath Self-reported perception of warmth and skin stimulus during the footbath, assessed with a dynamic warmth and skin stimulus visual analog scale (VAS), applied once per minute (0 = cold/no stimulus; 10 = very hot/very strong stimulus) Up to 20 minutes
Secondary Change in well-being from t1 to t2 Self-reported well-being, assessed with the "Basler Befindlichkeits-Skala" (Basel Mood Questionnaire, BBS; 16 items; 7-point rating scale; higher values Immediately before (t1) and immediately after the footbath (t2)
Secondary Change in well-being from t1 to t3 Self-reported well-being, assessed with the "Basler Befindlichkeits-Skala" (Basel Mood Questionnaire, BBS; 16 items; 7-point rating scale; higher values represent a better outcome) Immediately before (t1) and ten minutes following the footbath (t3)
Secondary Change in skin temperature at the feet from t1 to t3 Skin temperature (in °C) at both feet, measured with a high-definition infrared camera (FLIR-Systems, type SC660) Immediately before (t1) and ten minutes following the footbath (t3)
Secondary Change in skin temperature at the feet from t1 to t2 Skin temperature (in °C) at both feet, measured with a high-definition infrared camera (FLIR-Systems, type SC660) Immediately before the footbath (t1) and immediately after the footbath (t2)
Secondary Change in skin temperature at the hands from t1 to t3 Skin temperature (in °C) at both hands, measured with a high-definition infrared camera (FLIR-Systems, type SC660) Immediately before (t1) and ten minutes following the footbath (t3)
Secondary Change in skin temperature at the hands from t1 to t2 Skin temperature (in °C) at both hands, measured with a high-definition infrared camera (FLIR-Systems, type SC660) Immediately before the footbath (t1) and immediately after the footbath (t2)
Secondary Change in skin temperature in the face from t1 to t3 Skin temperature (in °C) in the face, measured with a high-definition infrared camera (FLIR-Systems, type SC660) Immediately before (t1) and ten minutes following the footbath (t3)
Secondary Change in skin temperature in the face from t1 to t2 Skin temperature (in °C) in the face, measured with a high-definition infrared camera (FLIR-Systems, type SC660) Immediately before the footbath (t1) and immediately after the footbath (t2)
See also
  Status Clinical Trial Phase
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT01210716 - Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device Phase 3
Completed NCT05478733 - Study of Factors Associated With Significant MYoCArdian Uptake on 68Ga-DOTATOC PET Scans for Oncology
Terminated NCT03978312 - Nutrition Health Literacy of Cancer Patients and Their Support Networks.
Not yet recruiting NCT04142463 - Collaborative Network to Take Responsibility for Oral Anticancer Therapy 2 N/A
Recruiting NCT06229535 - The Right to be Forgotten in the AYA Population: Patients' Experience and Perspectives (Diritto All'Oblio)
Completed NCT04420039 - Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction
Completed NCT03416465 - Place of General Medical During Oncology Care Management
Withdrawn NCT03041571 - Impact of Early Implementation of Narrative Medicine Techniques on Patient Centered Attitudes of Medical Students
Completed NCT02484053 - Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders Early Phase 1
Completed NCT03030248 - Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients Phase 2
Not yet recruiting NCT03168048 - Oncologic Therapy Support Via Means of a Dedicated Mobile App N/A
Completed NCT03426553 - Clinical Use of Pathogen Reduced Red Blood Cell Suspension Phase 3
Active, not recruiting NCT04842214 - Disease Course in Oncological Patients During Inpatient Rehabilitation and After Three Months Follow-up
Completed NCT03272646 - Prognostic Performance of the Naples Prognostic Score N/A
Terminated NCT02285296 - The Needs and Burden of Family Caregivers of Older Adults With Cancer N/A
Completed NCT04918888 - COVID-19 Vaccination in Oncologic Patients
Recruiting NCT05769868 - Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments Phase 3